Xavier Delavenne

23PUBLICATIONS
54CO-AUTHORS
Characterisation of biological macromoleculesCancer therapy (excl. chemotherapy and radiation therapy)HaematologyEpidemiological modellingPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|May 27, 2026
A comprehensive multicenter study assessing the impact of abelacimab, asundexian and milvexian on coagulation assays.

|Nov 25, 2025
Tinzaparin Pharmacokinetics in Patients with Cancer: A Comparative Modeling Study.

Xavier Delavenne, Jean Escal, Dominique Helley

|Oct 21, 2025
Modeling response to high-purity von Willebrand factor: toward tailored dosing during surgery in von Willebrand disease.

Mélanie Y Daniel, Antoine Rauch, Camille Paris

|Aug 22, 2025
F8 gene variants influence the response to desmopressin in hemophilia A carriers.

Benoît Guillet, Roseline d'Oiron, Marc Trossaert

|Jun 10, 2025
Development and Validation of a Liquid Chromatography High-Resolution Mass Spectrometry Method for Blood Desmopressin Quantification and Its Application in Hemophilia A Patients.

Sophie Hodin, Jean Escal, Catherine Feliu

|Jun 26, 2024
In Vitro/Ex Vivo Release Study of a Ground Umbilical Cord Matrix Loaded with Dexamethasone.

Florine Grossetete, Charlotte Garot, Emmanuel Crouzet

Pageof 4

Frequent Collaborators

5 joint publications

Edouard Ollier

3 joint publications

Yesim Dargaud

2 joint publications

Paul J Zufferey

2 joint publications

Virginie Siguret